Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Merck Drugs Added To Sichuan Essential Drug List

This article was originally published in PharmAsia News

Executive Summary

Merck recently announced the addition of its originator drug Zocor to Sichuan province's essential drug list. With the addition of two types of the cardiovascular drug to the list, prices will be cut by more than 50 percent. This is the first foreign originator drug to enter the province's essential drug list, and cardiovascular specialist Zhang Ting-Jie hopes the example set by Merck will influence other drug companies to seek essential drug listing and bring cheap, high-quality drugs to the people. He also notes that cardiovascular disease has become China's most common disease, with more than 1 million hypertensive patients in the Chengdu region alone. (Click Here For More - Chinese Language

Latest Headlines
See All
UsernamePublicRestriction

Register

SC074361

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel